Smith+Nephew Launches FLOW FLEXTEND COBLATION Wand
London, UK, August 17, 2026 Smith+Nephew, a global medical technology company, has announced the launch of its new FLOW...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
London, UK, August 17, 2026 Smith+Nephew, a global medical technology company, has announced the launch of its new FLOW...
SAN DIEGO, California, July 2, 2026 Circular Genomics has unveiled CircPATHâ„¢, its proprietary circular RNA (circRNA) discovery and validation...
ROSEMONT, Illinois, July 2, 2026 The American Academy of Orthopaedic Surgeons (AAOS) has released its first-ever Clinical Practice Guideline...
MINNEAPOLIS, Minn., July 1, 2026 Saluda Medical has achieved a major regulatory milestone with the U.S. Food and Drug...
YOKOHAMA, Japan, May 7, 2026 CoreTissue BioEngineering announced the initiation of the randomized controlled cohort in its ongoing clinical...
